Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T
在接受blinatumomab和自体CD19靶向CAR-T治疗失败后,供体来源的靶向CD19的CAR-NK细胞可使一名复发性B细胞急性淋巴细胞白血病(B-ALL)患儿达到完全缓解。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013714
Wang, Ning; Liu, Lipeng; Zhang, Luyang; Li, Jianqiang; Wan, Yang; Li, Xiaolan; Chen, Xia; Yin, Zixi; Zhang, Aoli; Zhang, Xiaoyan; Chen, Yumei; Hu, Tianyuan; Zhang, Yingchi; Liu, Fang; Zhu, Xiaofan; Yang, Wenyu
B细胞
白血病
细胞生物学
CAR-NK
CD19
免疫/内分泌